Advertisement
Advertisement

PROF

PROF logo

Profound Medical Corp. Common Stock

6.46
USD
Sponsored
+0.14
+2.18%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

6.47

+0.02
+0.26%

PROF Earnings Reports

Positive Surprise Ratio

PROF beat 15 of 39 last estimates.

38%

Next Report

Date of Next Report
Mar 04, 2026
Estimate for Q4 25 (Revenue/ EPS)
$7.54M
/
-$0.28
Implied change from Q3 25 (Revenue/ EPS)
+42.59%
/
+7.69%
Implied change from Q4 24 (Revenue/ EPS)
+80.54%
/
+40.00%

Profound Medical Corp. Common Stock earnings per share and revenue

On Nov 13, 2025, PROF reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.36 USD, resulting in a 29.48% surprise. Revenue reached 5.29 million, compared to an expected 5.04 million, with a 4.85% difference. The market reacted with a +7.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 7.54 million USD, implying an increase of 7.69% EPS, and increase of 42.59% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Profound Medical Corp. Common Stock reported EPS of -$0.26, beating estimates by 29.48%, and revenue of $5.29M, 4.85% above expectations.
The stock price moved up 7.87%, changed from $6.35 before the earnings release to $6.85 the day after.
The next earning report is scheduled for Mar 04, 2026.
Based on 5 analysts, Profound Medical Corp. Common Stock is expected to report EPS of -$0.28 and revenue of $7.54M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement